Circulating PCSK9 levels and 2-hPG are positively correlated in metabolic diseases in a Chinese Han population

Adiponectin potentiates the acute effects of leptin in arcuate Pomc neurons

(2016) Jia Sun et al.   Molecular Metabolism

Role of Insulin in the Regulation of Proprotein Convertase Subtilisin/Kexin Type 9Significance

(2015) Ji Miao et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Inter-relationships between proprotein convertase subtilisin/kexin type 9, apolipoprotein C-III and plasma apolipoprotein B-48 transport in obese subjects: a stable isotope study in the postprandial state

(2015) Dick C. Chan et al.   CLINICAL SCIENCE

The Relationship between the Plasma PCSK9 Levels and Platelet Indices in Patients with Stable Coronary Artery Disease

(2015) Sha Li et al.   Journal of Atherosclerosis and Thrombosis

Association of plasma PCSK9 levels with white blood cell count and its subsets in patients with stable coronary artery disease

(2014) Sha Li et al.   ATHEROSCLEROSIS

Relation of circulating PCSK9 concentration to fibrinogen in patients with stable coronary artery disease

(2014) Yan Zhang et al.   Journal of Clinical Lipidology

Improving the care of high-risk patients: The potential of PCSK9

(2013) Jane Stock   ATHEROSCLEROSIS

Two-hour post-load plasma glucose levels are associated with carotid intima-media thickness in subjects with normal glucose tolerance

(2013) K. Kato et al.   DIABETIC MEDICINE

Postchallenge responses of nitrotyrosine and TNF-alpha during 75-g oral glucose tolerance test are associated with the presence of coronary artery diseases in patients with prediabetes

(2012) Chih-Sheng Chu et al.   Cardiovascular Diabetology

PCSK9 siRNA suppresses the inflammatory response induced by oxLDL through inhibition of NF-κB activation in THP-1-derived macrophages

(2012) ZHIHAN TANG et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Serum PCSK9 is associated with multiple metabolic factors in a large Han Chinese population

(2010) Qin Cui et al.   ATHEROSCLEROSIS

Impaired glucose tolerance, but not impaired fasting glucose, is a risk factor for early-stage atherosclerosis

(2010) T. Ando et al.   DIABETIC MEDICINE

Molecular basis of PCSK9 function

(2008) Gilles Lambert et al.   ATHEROSCLEROSIS

Inflammation stimulates the expression of PCSK9

(2008) Kenneth R. Feingold et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS